Study of Lacutamab in Peripheral T-cell Lymphoma
Clinical trial NCT04984837 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04984837
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-05
- Primary completion
- 2028-04-30
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.